spacer
home > pmps > autumn 2018 > encounters in transportation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Encounters in Transportation

Supply chain logistics experts understand that the transportation of any type of goods comes with their own set of challenges. When cold chain logistics are taken into account, a new set of unique obstacles are introduced.

To start, the cold chain market is growing. According to Qy Research Groups’ Global Cold Chain Logistics Market Size, Status and Forecast 2022 report, the global cold chain market is expected to reach US $426.2 billion by 2022. Pharmaceutical Commerce reported that cold chain logistics spending is forecast to grow to more than US $16 billion by 2020. Data points back to the rising demand for pharmaceuticals as one of the main factors driving demand for the temperature-controlled supply chain. This demand also stems from an aging population, which, in turn, is starting to require more medication, which must stay at specified temperatures.

By 2050, 16% of the world’s population will be 65 or older. Baby Boomers started turning 65 in 2011, and the American Hospital Association projects that by 2030, more than 60% of this generation will be managing more than one chronic condition. Additionally, Milliman reports that increased life expectancies will trigger greater consumption patterns in the population for medical services and pharmaceuticals.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Angela Kerr is Vice President of product portfolio at SpotSee. In this role, Angela focusses on building the company’s existing business and developing the next generation of cloud-based products that help customers costeffectively track their products around the globe. She has a Bachelor of Science degree in electrical engineering from Texas Tech University, US.
spacer
Angela Kerr
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Organization Updates

Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following management updates to help drive the company’s future vision, strategy and growth.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement